IOVA
Iovance Biotherapeutics Inc.
Latest News for IOVA
In a report released today, from Mizuho Securities maintained a Buy rating on Iovance Biotherapeutics, with a price target of $10.00. In addition t......
Iovance Biotherapeutics (($IOVA)) has held its Q3 earnings call. Read on for the main highlights of the call. The recent earnings call of Iovance B......
In a report released today, Joseph Pantginis from H.C. Wainwright reiterated a Buy rating on Iovance Biotherapeutics, with a price target of $9.00.......
Barclays analyst Peter Lawson maintained a Buy rating on Iovance Biotherapeutics today and set a price target of $4.00. The company’s shares closed......
Iovance Biotherapeutics (($IOVA)) announced an update on their ongoing clinical study. Study Overview: Iovance Biotherapeutics is conducting a Phas......
Iovance Biotherapeutics (($IOVA)) announced an update on their ongoing clinical study. Study Overview: Iovance Biotherapeutics is conducting a Phas......
News data is sourced from MarketXLS API and updated regularly.
Showing 6 of 6 articles.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | IOVA | $2.23 | +2.3% | 6.19M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Iovance Biotherapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW